Business
Appointment of Interim Chief Scientific Officer
Appointment of Interim Chief Scientific Officer.
About this update from Valirx Plc
[{"type":"text","content":"\n \n \n 8 September 2022\n \n \n \n \n \n \n \n \n ValiRx PLC (\"ValiRx\" or the \"Company\")\n \n \n \n \n \n \n \n \n \n Appointment of Interim Chief Scientific Officer\n \n \n \n \n \n \n \n \n London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women's health is pleased to announce the appointment of Dr Catherine (\"Cathy\") Tralau-Stewart as interim Chief Scientific Officer (a non-board position).\n \n \n Dr Tralau-Stewart has experience working across leading pharmaceutical companies and academic groups, with a particular focus on the interaction between industry and academia. Her role within the Company will encompass the review of new, incoming science; enhancing the progress of existing projects; and influencing the overall strategic scientific direction of the Company.\n \n \n \n Dr Suzy Dilly, CEO of ValiRx PLC commented\n \n \"I'm delighted to have the opportunity to work with Cathy, I'm looking forward to having another in-house scientist with whom to share ideas and to develop and deliver upon our strategic ambitions. Cathy's wealth of experience in exactly the areas in which we wish to progress, makes her an excellent choice for this role.\"\n \n \n The Directors of the Company take responsibility for this announcement.\n \n \n *** ENDS ***\n \n \n \n \n \n For more information, please contact:\n \n \n \n \n \n \n \n \n \n \n ValiRx plc\n \n \n \n \n \n \n Dr Suzanne Dilly, CEO\n \n \n \n \n \n Dr Adam Hargreaves, Shareholder Representative\n \n \n \n \n \n \n \n \n Tel: +44 (0) 2476 796496\n \n \n \n \n \n www.valirx.com\n \n \n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n V Formation (Public Relations)\n \n \n \n \n \n \n \n \n Lucy Wharton - Senior PR Executive\n \n \n Sue Carr - Director\n \n \n \n \n \n \n \n \n \n \n +44 (0) 115 787 0206\n \n \n \n \n www.vformation.biz\n \n \n \n \n \n \n \n \n [email protected]\n \n \n [email protected]\n \n \n \n \n \n \n \n Cairn Financial Advisers LLP (Nominated Adviser)\n \n \n \n \n \n \n Liam Murray/Jo Turner/Ludovico Lazzaretti\n \n \n \n \n \n \n \n \n Tel: +44 (0) 20 7213 0880\n \n \n \n \n \n \n \n \n Cenkos Securities plc (Joint...